The Alzheimer's drug that did not need to demonstrate its clinical efficacy to go on the market sparks criticism
There is an urgent need in the world to find a treatment that is truly effective against Alzheimer's. It is estimated that around 40 million people suffer from this dementia and the progressive aging of the populations of multiple countries, together with the increase in life expectancy, will cause this figure to increase in the coming decades. Today, no drug on the market has been shown to be capable of preventing or delaying the cognitive decline caused by this pathology. Drugs on the market can only temporarily relieve some symptoms or slow their worsening slightly.